Johnson & Johnson faces high-stakes hearing over ‘Texas Two Step’ talc strategy: report
Johnson & Johnson faces high-stakes hearing over ‘Texas Two Step’ [...]
Johnson & Johnson faces high-stakes hearing over ‘Texas Two Step’ [...]
Surprise COVID-19 antibody sales of $804M help Regeneron trounce expectations [...]
Yet another Acceleron investor challenges Merck’s $11.5B acquisition offer: Bloomberg [...]
After a phase of slower growth, Novo Nordisk sees the [...]
By unanimous vote, CDC advisory committee endorses Pfizer COVID-19 vaccine [...]
Novartis teams with advocacy group to bring visibility to atherosclerotic [...]
Stallergenes, seeking an edge in a competitive space, taps Aptar [...]
AbbVie’s Parkinson’s pump hits goal in phase 3, setting stage [...]
Pfizer’s COVID vaccine for younger kids meets FDA bar, with [...]
Seagen stands by newly acquired HER2 breast cancer drug despite [...]